PartsTable TECHNICAL DATA SHEET
NSN 6505-01-344-5259Government record, cited

Ceftazidime for Injection6505-01-344-5259

NSN 6505-01-344-5259 · NIIN 013445259 · Part number NDC00173-0418-00
Glaxo Wellcome Inc · FSC 6505 — Drugs and Biologicals · FSG 65 — Medical, Dental, and Veterinary Equipment · CAGE 34006
Government record, cited
NSN 6505-01-344-5259 — this item is cataloged by the U.S. Government under National Stock Number 6505-01-344-5259. Manufacturer of record part number: NDC00173-0418-00.
Also searched as  6505-01-344-5259 · 6505013445259 · NIIN 013445259 · 01-344-5259 · FSC 6505 Drugs and Biologicals · CAGE 34006 · NDC00173-0418-00 · CEPTAZ
Nearby stock numbers  ·
Features
  • Ceftazidime for Injection — FSC 6505
  • Primary Container Content Quantity: 10.000 GRAMS G
  • Medical Designation and Grade: UNITED STATES PHARMACOPEIA
  • Primary Container Type: VIAL
  • Physical Form: POWDER
  • Total Primary Container Quantity: 6
  • 1 manufacturer part number on file
  • Manufacturer of record: Glaxo Wellcome Inc
Identification
  • NSN: 6505-01-344-5259
  • NIIN: 013445259
  • FSC: 6505 — Drugs and Biologicals
  • FSG: 65 — Medical, Dental, and Veterinary Equipment
  • Primary part number: NDC00173-0418-00
  • Manufacturer: Glaxo Wellcome Inc
General Description

The Ceftazidime for Injection, cataloged under National Stock Number 6505-01-344-5259, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Glaxo Wellcome Inc. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.

Technical Specifications
ParameterValue
NSN6505-01-344-5259
Primary Part NumberNDC00173-0418-00
Item NameCeftazidime for Injection
FSC / FSG6505 / 65 — Drugs and Biologicals
ManufacturerGlaxo Wellcome Inc
StatusACTIVE
Primary Container Content Quantity10.000 GRAMS G
Medical Designation and GradeUNITED STATES PHARMACOPEIA
Primary Container TypeVIAL
Physical FormPOWDER
Total Primary Container Quantity6
Lifecycle & Compliance
Acquisition StatusACTIVE
DEMIL CodeDEMIL A — No Demilitarization Required
HazardPossible hazard — SDS may be required (DLA HMIC P)
Criticality CodeX
Cross-Reference Index
Part NumberManufacturer
NDC00173-0418-00 PRIMARY Glaxo Wellcome Inc (USA)
Reference documents
ReferenceMeaning
CEPTAZ 5/1 Secondary reference
Glaxo Wellcome Inc

Frequently Asked Questions

What is NSN 6505-01-344-5259?

NSN 6505-01-344-5259 is a Ceftazidime for Injection, manufactured by Glaxo Wellcome Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.

What part numbers are listed for NSN 6505-01-344-5259?

NSN 6505-01-344-5259 has 1 manufacturer part number on file: NDC00173-0418-00 (Glaxo Wellcome Inc).

What are the specifications of NDC00173-0418-00?

Key specifications for NDC00173-0418-00: Primary Container Content Quantity: 10.000 GRAMS G; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL; Physical Form: POWDER. 5 specifications are documented in the U.S. Government catalog.

Is NSN 6505-01-344-5259 hazardous material?

Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.

Sources

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.

✓ Data cited from the U.S. Government catalog; commercial cross-references from OEM and certified industry sources.
PartsTable Design LLC · partstable.com